ROYAL BANK OF CANADA - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAA4. A total of 10 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$4,0000.0%4,0000.0%0.00%
Q3 2018$4,0000.0%4,0000.0%0.00%
Q2 2018$4,0000.0%4,0000.0%0.00%
Q1 2018$4,0000.0%4,0000.0%0.00%
Q4 2017$4,0000.0%4,0000.0%0.00%
Q3 2017$4,0000.0%4,0000.0%0.00%
Q2 2017$4,0004,0000.00%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Birch Grove Capital LP 17,250,000$19,597,00018.38%
STEELHEAD PARTNERS LLC 17,000,000$19,264,0001.88%
Bruce & Co., Inc. 5,500,000$6,600,0001.78%
STELLIAM INVESTMENT MANAGEMENT, LP 26,750,000$30,177,0001.01%
Castle Creek Arbitrage, LLC 3,721,000$4,215,0000.43%
LINDEN ADVISORS LP 7,000,000$7,909,0000.36%
Sonora Investment Management, LLC 1,510,000$1,702,676,0000.36%
BASSO CAPITAL MANAGEMENT, L.P. 2,110,000$2,382,0000.35%
WOLVERINE ASSET MANAGEMENT LLC 18,400,000$20,808,0000.31%
SSI INVESTMENT MANAGEMENT LLC 1,975,000$2,221,0000.20%
View complete list of AMAG PHARMACEUTICALS INC shareholders